Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2026-03-02 @ 6:08 PM
Study NCT ID:
NCT01605734
Status:
UNKNOWN
Last Update Posted:
2012-05-25
First Post:
2012-05-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TACE Combinated With Sorafenib in Treating Patients With Unresectable Hepatocellular Carcinoma
Sponsor:
Shandong Cancer Hospital and Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ShandongCHI-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None